Prof. Oliver Sartor Joins Clarity’s Advisory Board
Sydney, Australia 19 March 2020 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Prof. Oliver Sartor has joined Clarity’s Advisory Board. Prof. Sartor is a medical oncologist and an internationally recognised expert in prostate cancer. He is the Laborde Professor for Cancer Research, Medical Director…